Literature DB >> 25668672

Prevalence of rotavirus antibodies in breast milk and inhibitory effects to rotavirus vaccines.

Nguyen V Trang1, Tessa Braeckman, Tinne Lernout, Vu T B Hau, Le T K Anh, Le T Luan, Pierre Van Damme, Dang D Anh.   

Abstract

Rotavirus (RV) is the most common cause of childhood diarrhea worldwide, and several vaccines have been successfully developed to reduce the burden of disease. However, lower vaccine immunogenicity and efficacy in developing countries might be related to the virus-neutralizing activity of breast milk. We examined possible differences in breast milk antibody levels (total IgA antibody, RV-specific antibodies, and RV-neutralizing antibodies) between healthy mothers living in a rural area (n=145) and mothers living in an urban area (n=147) of Vietnam. Total IgA concentration was significantly higher in samples from mothers in the rural region than in samples from mothers in the urban region, whereas urban mothers had significantly higher RV-specific IgA antibody titers than did rural mothers. Neutralizing antibodies against RV strain G1P[8] were undetected in nearly one-half of the breast milk samples (45-48%), whereas the majority of the remaining samples had low antibody titers (2-16). Despite these low titers, the breast milk still reduced vaccine strain titers (2×10(6) plaque forming units/mL) up to 80% or more, even at a milk-to-virus ratio of 1:8. An increase in neutralizing anti-G1P[8] antibody titers (P<0.05) in rural infants over time suggests a continuous exposure to circulating RV. These results contribute to the understanding of the potential interference of breast milk with RV vaccine efficacy and immunogenicity in Vietnamese infants.

Entities:  

Keywords:  DTP, diphtheria–tetanus–pertussis; ELISA, Enzyme linked immunosorbent assay; G1-VN, neutralizing antibodies against G1P[8]; G4-VN, neutralizing antibodies against G4P[6]; HCl, Hydrogen chloride; HRP, Horseradish peroxidase; IgA; IgA, Immunoglobulin A; IgG, Immunoglobulin G; MEM, Minimal essential medium; NIHE, National Institute of Hygiene and Epidemiology; OD, Optical density; P-RV, Rotavirus strain P; PBS, Phosphate-buffered saline; PFU, Plaque-forming unit; POLYVAC, Center for Production of Vaccines and Biologicals; RRV, Rhesus rotavirus; RV, Rotavirus; SE, Standard error;; TMB, 3, 3′, 5, 5′-Tetramethylbenzidine; Vietnam; breast milk; neutralizing antibody; rotavirus

Mesh:

Substances:

Year:  2014        PMID: 25668672      PMCID: PMC4514039          DOI: 10.4161/21645515.2014.980204

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  25 in total

1.  Epidemiological profile and burden of rotavirus diarrhea in Vietnam: 5 years of sentinel hospital surveillance, 1998-2003.

Authors:  Nguyen Van Man; Le Thi Luan; Dang Duc Trach; Nguyen Thi Hien Thanh; Phan Van Tu; Nguyen Thanh Long; Dang Duc Anh; Thea K Fischer; Bernard Ivanoff; Jon R Gentsch; Roger I Glass
Journal:  J Infect Dis       Date:  2005-09-01       Impact factor: 5.226

2.  The epidemiology and disease burden of rotavirus in Vietnam: sentinel surveillance at 6 hospitals.

Authors:  V M Nguyen; V T Nguyen; P L Huynh; D T Dang; T H Nguyen; V T Phan; T L Nguyen; T L Le; B Ivanoff; J R Gentsch; R I Glass
Journal:  J Infect Dis       Date:  2001-05-16       Impact factor: 5.226

3.  Serum, fecal, and breast milk rotavirus antibodies as indices of infection in mother-infant pairs.

Authors:  R F Bishop; H C Bugg; P J Masendycz; J S Lund; R J Gorrell; G L Barnes
Journal:  J Infect Dis       Date:  1996-09       Impact factor: 5.226

4.  Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam.

Authors:  Thea K Fischer; Dang Duc Anh; Lynn Antil; N D L Cat; Paul E Kilgore; Vu D Thiem; Rick Rheingans; Le H Tho; Roger I Glass; Joseph S Bresee
Journal:  J Infect Dis       Date:  2005-10-14       Impact factor: 5.226

5.  Rotavirus-specific breast milk antibody in two populations and possible correlates of interference with rhesus rotavirus vaccine seroconversion.

Authors:  H C Rimer; S S Wasserman; J Flores; M E Pichichero; G A Losonsky
Journal:  J Infect Dis       Date:  1992-05       Impact factor: 5.226

6.  Role of human-milk lactadherin in protection against symptomatic rotavirus infection.

Authors:  D S Newburg; J A Peterson; G M Ruiz-Palacios; D O Matson; A L Morrow; J Shults; M L Guerrero; P Chaturvedi; S O Newburg; C D Scallan; M R Taylor; R L Ceriani; L K Pickering
Journal:  Lancet       Date:  1998-04-18       Impact factor: 79.321

Review 7.  Human milk glycoconjugates that inhibit pathogens.

Authors:  D S Newburg
Journal:  Curr Med Chem       Date:  1999-02       Impact factor: 4.530

8.  Effect of maternal rotavirus immunization on milk and serum antibody titers.

Authors:  L K Pickering; A L Morrow; I Herrera; M O'Ryan; M K Estes; S E Guilliams; L Jackson; S Carter-Campbell; D O Matson
Journal:  J Infect Dis       Date:  1995-09       Impact factor: 5.226

9.  Inhibitory effects of human and bovine milk constituents on rotavirus infections.

Authors:  A S Kvistgaard; L T Pallesen; C F Arias; S López; T E Petersen; C W Heegaard; J T Rasmussen
Journal:  J Dairy Sci       Date:  2004-12       Impact factor: 4.034

10.  Global illness and deaths caused by rotavirus disease in children.

Authors:  Umesh D Parashar; Erik G Hummelman; Joseph S Bresee; Mark A Miller; Roger I Glass
Journal:  Emerg Infect Dis       Date:  2003-05       Impact factor: 6.883

View more
  3 in total

Review 1.  Contribution of Maternal Immunity to Decreased Rotavirus Vaccine Performance in Low- and Middle-Income Countries.

Authors:  Katayi Mwila; Roma Chilengi; Michelo Simuyandi; Sallie R Permar; Sylvia Becker-Dreps
Journal:  Clin Vaccine Immunol       Date:  2017-01-05

2.  In-vitro inhibitory effect of maternal breastmilk components on rotavirus vaccine replication and association with infant seroconversion to live oral rotavirus vaccine.

Authors:  Katayi Mwila Kazimbaya; Caroline C Chisenga; Michelo Simuyandi; Cynthia Mubanga Phiri; Natasha Makabilo Laban; Samuel Bosomprah; Sallie R Permar; Sody Munsaka; Roma Chilengi
Journal:  PLoS One       Date:  2020-11-10       Impact factor: 3.240

3.  Maternal antibody interference contributes to reduced rotavirus vaccine efficacy in developing countries.

Authors:  Claire E Otero; Stephanie N Langel; Maria Blasi; Sallie R Permar
Journal:  PLoS Pathog       Date:  2020-11-19       Impact factor: 6.823

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.